AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 135.3 SEK 0.3% Market Closed
Market Cap: 16.5B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AddLife AB
Capital Expenditures Peer Comparison

Comparables:
BICO
BIOT
G
GENO
MCAP
M
MAGLE

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Capital Expenditures
-kr308m
CAGR 3-Years
-49%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Capital Expenditures
-kr291.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Capital Expenditures
-kr163m
CAGR 3-Years
-37%
CAGR 5-Years
-31%
CAGR 10-Years
-17%
G
Genovis AB
STO:GENO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Capital Expenditures
-kr57.8m
CAGR 3-Years
-22%
CAGR 5-Years
-50%
CAGR 10-Years
-21%
M
Magle Chemoswed Holding AB
STO:MAGLE
Capital Expenditures
-kr15.1m
CAGR 3-Years
-24%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is AddLife AB's Capital Expenditures?
Capital Expenditures
-308m SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Capital Expenditures amounts to -308m SEK.

What is AddLife AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-44%

Over the last year, the Capital Expenditures growth was -9%. The average annual Capital Expenditures growth rates for AddLife AB have been -49% over the past three years , -44% over the past five years .

Back to Top